Federal health officials announced Wednesday they will begin moving to decertify a Kentucky organ procurement group after allegations that the agency pressed ahead with donation plans for patients who later showed signs of recovery. With more than 100,000 people waiting for transplants nationwide, the action raises immediate questions about oversight and patient safety in the organ donation system.
The group at the center of the controversy, Network for Hope, is one of roughly 55 regional organ procurement organizations (OPOs) that coordinate donations from deceased donors and help match organs to people on transplant lists. Health Secretary Robert F. Kennedy Jr. said the nonprofit had demonstrated what he described as “ongoing safety lapses” and that the government is starting a formal decertification process.
Network for Hope disputed the characterization and said it will challenge the move. In a written response the organization said it follows federal rules and will pursue an appeal of the department’s decision.
US halts operations of Kentucky organ donor group over safety lapses
Colorado fugitive captured in Cheyenne following intense SWAT operation
At the heart of the allegations is a 2021 case in which the procurement agency’s predecessor is accused of urging a hospital to proceed with withdrawal of life support and organ retrieval for a man after an overdose, even as medical staff reported signs that he was regaining consciousness. The patient ultimately survived; his sister stood with Kennedy at a press briefing to thank officials for initiating action.
It is important to note how the donation process is supposed to work: only the treating physician can formally declare a patient dead. After that declaration, an OPO may take responsibility for identifying potential recipients and arranging surgical teams. Most donations occur after a diagnosis of brain death; in other instances, when a patient has a nonsurvivable injury and the family elects to withdraw life support, donation can proceed under carefully defined conditions.
Network for Hope says it has already implemented additional safeguards. More than a year ago the group adopted a protocol — described by the agency as a first-of-its-kind measure — that lets hospital staff, family members or other clinicians call a halt to donation planning if there are concerns about a patient’s suitability.
Kentucky lawmakers recently enacted a law requiring such a pause, and the federal Organ Procurement and Transplantation Network (OPTN) is developing rules that would extend a similar requirement to all U.S. OPOs. That regulatory work is ongoing and could change national practice.
- Allegation: A 2021 incident in which donation planning moved forward despite signs the patient might recover.
- Agency response: Network for Hope denies violations, says it follows federal policy and will appeal the decertification action.
- Regulatory changes: Kentucky law now mandates a pause in donation planning; OPTN is drafting nationwide rules.
- Potential impact: Decertification could remove an OPO from the federal system and require replacement or a reconfiguration of services in its region.
The dispute unfolds against a stark backdrop: more than 100,000 people are on the U.S. transplant waiting list, most seeking a kidney, and thousands die each year while waiting. Last year saw a record number of transplants — more than 49,000 — even as the total fell slightly from the previous year, the first dip in about a decade.
What happens next will depend on the federal review and any legal proceedings brought by Network for Hope. If the decertification is finalized, federal officials could revoke the agency’s status, paving the way for another organization to assume responsibility for organ procurement in the affected area — a change that could carry both logistical challenges and public-relations consequences as regulators weigh patient safety against the urgency of maintaining organ supply.
For now, the case has highlighted tensions between the need for strict safeguards in donation practices and the pressure to maximize organ availability for patients on long waiting lists. Federal officials and transplant advocates say the coming weeks will be critical for determining how national policy and local practice will adapt.
